Ray Dalio's position in Regeneron Pharmaceuticals is currently worth $153 Thousand. That's 0.00% of their equity portfolio (655th largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Ray Dalio bought shares sixteen more times and sold shares on nineteen occasions. The investor's estimated purchase price is $209 Thousand, resulting in a loss of 27%.